Levothyroxine Sodium
- Product NDC
- 51655-923
- 11-digit product format
- 516550923
- Labeler code
- 51655
- Product ID
- 51655-923_4a9059c0-519e-75f5-e063-6394a90a1e03
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA209713
- Marketing category
- ANDA
- Marketing start
- 2022-03-04
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- .1 mg/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | .1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 892246 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51655-923-52 | Levothyroxine Sodium | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-923 | LEVOTHYROXINE SODIUM TABLET [NORTHWIND PHARMACEUTICALS, LLC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240814_d9dfd5b8-06a5-2728-e053-2995a90a298e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-923-52 | 51655092352 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-923-52) | 30 tablet | 2022-03-04 | 0000-00-00 | No | No | Current |